MITE in the Treatment of Dyspepsia After Cholecystectomy
Status:
Not yet recruiting
Trial end date:
2022-02-01
Target enrollment:
Participant gender:
Summary
To confirm the clinical efficacy of Compound Azintamide Enteric-coated Tablets in the
treatment of patients with dyspepsia after cholecystectomy (such as abdominal distension,
abdominal pain/abdominal discomfort, diarrhea/fatty stool, early satiety, belching, loss of
appetite, etc.) by comparing with positive control drug, to observe its safety, and to
evaluate the quality of life of subjects before and after treatment
Phase:
Phase 4
Details
Lead Sponsor:
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine